SRL
MREO

Scientech Research LLC’s Mereo BioPharma MREO Stock Holding History

Scientech Research LLC’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,124
Closed -$20.9K – 695
2025
Q3 		$20.9K Buy
+10,124
New +$18.7K 0.01% 533
2024
Q1 		– Sell
-13,955
Closed -$32.2K – 514
2023
Q4 		$32.2K Buy
+13,955
New +$26.7K 0.03% 288

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Scientech Research LLC's MREO Position: Q4 2025 in Review

Scientech Research LLC sold out of Mereo BioPharma (MREO) in Q4 2025, closing a stake of 10,124 shares — an estimated $20.9K sold.

Scientech Research LLC first reported a position in MREO in Q4 2023 and held it in 2 quarters. The position peaked at $32.2K in Q4 2023. 70 funds tracked by Wall St. Rank hold MREO as of Q4 2025.

  • Scientech Research LLC reported no remaining Mereo BioPharma position as of Q4 2025 after selling out during the quarter.
  • Scientech Research LLC sold 10,124 Mereo BioPharma shares in Q4 2025, an estimated $20.9K.
  • Scientech Research LLC first reported a position in Mereo BioPharma in Q4 2023 and held it in 2 quarters.
  • Scientech Research LLC's Mereo BioPharma position peaked at $32.2K in Q4 2023.
  • 70 funds tracked by Wall St. Rank held Mereo BioPharma as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.